Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Parasitol ; 41(3-4): 417-27, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21163263

RESUMO

Protein translation in the plastid (apicoplast) of Plasmodium spp. is of immense interest as a target for potential anti-malarial drugs. However, the molecular data on apicoplast translation needed for optimisation and development of novel inhibitors is lacking. We report characterisation of two key translation elongation factors in Plasmodium falciparum, apicoplast-encoded elongation factor PfEF-Tu and nuclear-encoded PfEF-Ts. Recombinant PfEF-Tu hydrolysed GTP and interacted with its presumed nuclear-encoded partner PfEF-Ts. The EF-Tu inhibitor kirromycin affected PfEF-Tu activity in vitro, indicating that apicoplast EF-Tu is indeed the target of this drug. The predicted PfEF-Ts leader sequence targeted GFP to the apicoplast, confirming that PfEF-Ts functions in this organelle. Recombinant PfEF-Ts mediated nucleotide exchange on PfEF-Tu and homology modeling of the PfEF-Tu:PfEF-Ts complex revealed PfEF-Ts-induced structural alterations that would expedite GDP release from PfEF-Tu. Our results establish functional interaction between two apicoplast translation factors encoded by genes residing in different cellular compartments and highlight the significance of their sequence/structural differences from bacterial elongation factors in relation to inhibitor activity. These data provide an experimental system to study the effects of novel inhibitors targeting PfEF-Tu and PfEF-Tu.PfEF-Ts interaction. Our finding that apicoplast EF-Tu possesses chaperone-related disulphide reductase activity also provides a rationale for retention of the tufA gene on the plastid genome.


Assuntos
Núcleo Celular/metabolismo , Fator Tu de Elongação de Peptídeos/metabolismo , Fatores de Alongamento de Peptídeos/metabolismo , Plasmodium falciparum/metabolismo , Plastídeos/metabolismo , Biossíntese de Proteínas , Animais , Antibacterianos/farmacologia , Núcleo Celular/genética , Modelos Moleculares , Fator Tu de Elongação de Peptídeos/química , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/genética , Fatores de Alongamento de Peptídeos/química , Fatores de Alongamento de Peptídeos/genética , Plasmodium falciparum/genética , Plasmodium falciparum/crescimento & desenvolvimento , Plasmodium falciparum/ultraestrutura , Plastídeos/genética , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Piridonas/farmacologia
2.
RNA ; 13(12): 2091-7, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17951333

RESUMO

Ribosome-stimulated hydrolysis of guanosine-5'-triphosphate (GTP) by guanosine triphosphatase (GTPase) translation factors drives protein synthesis by the ribosome. Allosteric coupling of GTP hydrolysis by elongation factor Tu (EF-Tu) at the ribosomal GTPase center to messenger RNA (mRNA) codon:aminoacyl-transfer RNA (aa-tRNA) anticodon recognition at the ribosomal decoding site is essential for accurate and rapid aa-tRNA selection. Here we use single-molecule methods to investigate the mechanism of action of the antibiotic thiostrepton and show that the GTPase center of the ribosome has at least two discrete functions during aa-tRNA selection: binding of EF-Tu(GTP) and stimulation of GTP hydrolysis by the factor. We separate these two functions of the GTPase center and assign each to distinct, conserved structural regions of the ribosome. The data provide a specific model for the coupling between the decoding site and the GTPase center during aa-tRNA selection as well as a general mechanistic model for ribosome-stimulated GTP hydrolysis by GTPase translation factors.


Assuntos
RNA Mensageiro/genética , RNA de Transferência/genética , Ribossomos/fisiologia , Tioestreptona/farmacologia , Antibacterianos/farmacologia , GTP Fosfo-Hidrolases/metabolismo , Guanosina Trifosfato/metabolismo , Modelos Moleculares , Biologia Molecular , Conformação de Ácido Nucleico , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/metabolismo , RNA de Transferência/efeitos dos fármacos , Ribossomos/efeitos dos fármacos , Espectrometria de Fluorescência
3.
FEBS Lett ; 580(19): 4576-81, 2006 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-16876786

RESUMO

Elongation factor Tu (EF-Tu), the carrier of aa-tRNA to the mRNA-programmed ribosome, is the target of four families of antibiotics of unrelated structure, of which the action is supported by two basic mechanisms. Kirromycin and enacyloxin block EF-Tu.GDP on the ribosome; pulvomycin and GE2270 A inhibit the interaction of EF-Tu.GTP with aa-tRNA. The crystallographic analysis has unveiled the structural background of their actions, explaining how antibiotics of unrelated structures and binding modes and sites can employ similar mechanism of action. The selective similarities and differences of their binding sites and the induced EF-Tu conformations make understand how nature can affect the activities of a complex regulatory enzyme by means of low-molecular compounds, and have proposed a suitable approach for drug design.


Assuntos
Antibacterianos/farmacologia , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Antibacterianos/química , Sítios de Ligação , Modelos Moleculares , Estrutura Molecular , Fator Tu de Elongação de Peptídeos/química , Relação Estrutura-Atividade
4.
Biochemistry ; 45(22): 6846-57, 2006 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-16734421

RESUMO

Pulvomycin inhibits protein synthesis by preventing the formation of the ternary complex between elongation factor Tu (EF-Tu) x GTP and aa-tRNA. In this work, the crystal structure of Thermus thermophilus EF-Tu x pulvomycin in complex with the GTP analogue guanylyl imino diphosphate (GDPNP) at 1.4 A resolution reveals an antibiotic binding site extending from the domain 1-3 interface to domain 2, overlapping the domain 1-2-3 junction. Pulvomycin binding interferes with the binding of the 3'-aminoacyl group, the acceptor stem, and 5' end of tRNA. Only part of pulvomycin overlaps the binding site of GE2270 A, a domain 2-bound antibiotic of a structure unrelated to pulvomycin, which also hinders aa-tRNA binding. The structure of the T. thermophilus EF-Tu x GDPNP x GE2270 A complex at 1.6 A resolution shows that GE2270 A interferes with the binding of the 3'-aminoacyl group and part of the acceptor stem of aa-tRNA but not with the 5' end. Both compounds, pulvomycin more markedly, hinder the correct positioning of domain 1 over domains 2 and 3 that characterizes the active form of EF-Tu, while they affect the domain 1 switch regions that control the EF-Tu x GDP/GTP transitions in different ways. This work reveals how two antibiotics with different structures and binding modes can employ a similar mechanism of action.


Assuntos
Aminoglicosídeos/química , Antibacterianos/química , Fator Tu de Elongação de Peptídeos/química , Peptídeos Cíclicos/farmacologia , Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Cristalografia , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Peptídeos Cíclicos/química , Fenilalanina-tRNA Ligase/química , Conformação Proteica , Thermus thermophilus/efeitos dos fármacos , Thermus thermophilus/metabolismo , Tiazóis/química , Tiazóis/farmacologia
5.
Nature ; 389(6649): 403-6, 1997 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-9311785

RESUMO

The delivery of a specific amino acid to the translating ribosome is fundamental to protein synthesis. The binding of aminoacyl-transfer RNA to the ribosome is catalysed by the elongation factor Tu (EF-Tu). The elongation factor, the aminoacyl-tRNA and GTP form a stable 'ternary' complex that binds to the ribosome. We have used electron cryomicroscopy and angular reconstitution to visualize directly the kirromycin-stalled ternary complex in the A site of the 70S ribosome of Escherichia coli. Electron cryomicroscopy had previously given detailed ribosomal structures at 25 and 23 A resolution, and was used to determine the position of tRNAs on the ribosome. In particular, the structures of pre-translocational (tRNAs in A and P sites) and post-translocational ribosomes (P and E sites occupied) were both visualized at a resolution of approximately 20 A. Our three-dimensional reconstruction at 18 A resolution shows the ternary complex spanning the inter-subunit space with the acceptor domain of the tRNA reaching into the decoding centre. Domain 1 (the G domain) of the EF-Tu is bound both to the L7/L12 stalk and to the 50S body underneath the stalk, whereas domain 2 is oriented towards the S12 region on the 30S subunit.


Assuntos
Escherichia coli/metabolismo , Fator Tu de Elongação de Peptídeos/metabolismo , Ribossomos/metabolismo , Cristalografia por Raios X , Escherichia coli/genética , Guanosina Trifosfato/química , Guanosina Trifosfato/metabolismo , Modelos Moleculares , Conformação de Ácido Nucleico , Fator Tu de Elongação de Peptídeos/química , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/ultraestrutura , Conformação Proteica , Piridonas/farmacologia , RNA de Transferência/metabolismo , Ribossomos/química , Ribossomos/efeitos dos fármacos , Ribossomos/ultraestrutura
6.
Microbiology (Reading) ; 143 ( Pt 2): 617-624, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9043138

RESUMO

The antibiotic kirromycin (Kr) inhibits bacterial protein synthesis by binding to elongation factor Tu (EF-Tu). Streptomyces cinnamoneus and Nocardia lactamdurans, producers of antibiotics of the Kr class, are known to possess an EF-Tu resistant to Kr. Both micro-organisms appear to possess a single tuf gene and we have characterized the one from S. cinnamoneus, which belongs to the tuf1 family. To assess the molecular determinants of Kr resistance, the S. cinnamoneus tuf gene was expressed in Escherichia coli as a translational fusion to malE, which enabled the recovery by affinity chromatography of the recombinant protein uncontaminated by the host factor. The recombinant EF-Tu was able to catalyse polyU-directed polyPhe synthesis in two heterologous cell-free systems, even as an uncleaved fusion. When tested for antibiotic sensitivity it behaved like the natural S. cinnamoneus protein, showing equivalent resistance to Kr but sensitivity to the antibiotic GE2270, indicating that all the determinants for Kr resistance are intrinsic to the EF-Tu sequence. Multiple sequence analysis of EF-Tu proteins, together with knowledge of mutations conferring Kr resistance, allowed the identification of key residues as likely candidates for the natural Kr resistance of the S. cinnamoneus EF-Tu. One of these, Thr378, was mutated to the consensus Ala and the resulting mutant protein was sensitive to Kr. Interestingly, it retained some activity (30% of the control) even at high Kr concentrations.


Assuntos
Antibacterianos/farmacologia , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Piridonas/metabolismo , Streptomyces/efeitos dos fármacos , Sequência de Aminoácidos , Sequência de Bases , Relação Dose-Resposta a Droga , Resistência Microbiana a Medicamentos/genética , Genes Bacterianos , Dados de Sequência Molecular , Fator Tu de Elongação de Peptídeos/biossíntese , Fator Tu de Elongação de Peptídeos/genética , Biossíntese de Proteínas/efeitos dos fármacos , Piridonas/farmacologia , Proteínas Recombinantes de Fusão/biossíntese , Mapeamento por Restrição , Homologia de Sequência de Aminoácidos , Homologia de Sequência do Ácido Nucleico , Especificidade da Espécie , Streptomyces/genética
7.
EMBO J ; 13(21): 5113-20, 1994 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-7957075

RESUMO

This paper reports the generation of Escherichia coli mutants resistant to pulvomycin. Together with targeted mutagenesis of the tufA gene, conditions were found to overcome membrane impermeability, thereby allowing the selection of three mutants harbouring elongation factor (EF)-Tu Arg230-->Cys, Arg333-->Cys or Thr334-->Ala which confer pulvomycin resistance. These mutations are clustered in the three-domain junction interface of the crystal structure of the GTP form of Thermus thermophilus EF-Tu. This result shares similarities with kirromycin resistance; kirromycin-resistant mutations cluster in the domain 1-3 interface. Since both interface regions are involved in the EF-Tu switch mechanism, we propose that pulvomycin and kirromycin both act by specifically disturbing the allosteric changes required for the switch from EF-Tu-GTP to EF-Tu-GDP. The three-domain junction changes dramatically in the switch to EF-Tu.GDP; in EF-Tu.GDP this region forms an open hole. Structural analysis of the mutation positions in EF-Tu.GTP indicated that the two most highly resistant mutants, R230C and R333C, are part of an electrostatic network involving numerous residues. All three mutations appear to destabilize the EF-Tu.GTP conformation. Genetic and protein characterizations show that sensitivity to pulvomycin is dominant over resistance. This appears to contradict the currently accepted model of protein synthesis inhibition by pulvomycin.


Assuntos
Aminoglicosídeos , Antibacterianos/farmacologia , Escherichia coli/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Peptídeos , Sítios de Ligação/genética , Permeabilidade da Membrana Celular , Relação Dose-Resposta a Droga , Resistência Microbiana a Medicamentos , Escherichia coli/genética , Genes Bacterianos/genética , Guanosina Trifosfato/química , Modelos Biológicos , Modelos Moleculares , Conformação Molecular , Mutagênese Sítio-Dirigida , Biossíntese Peptídica , Biossíntese de Proteínas/efeitos dos fármacos , Piridonas/farmacologia , Aminoacil-RNA de Transferência/metabolismo , RNA de Transferência de Fenilalanina/metabolismo , Seleção Genética , Relação Estrutura-Atividade
8.
J Mol Biol ; 242(5): 644-54, 1994 Oct 07.
Artigo em Inglês | MEDLINE | ID: mdl-7932721

RESUMO

A remarkable positive cooperativity between the GTPase activities of EF-Tu and EF-G on empty ribosomes from Escherichia coli has been discovered. This cooperativity implies a decrease of the corresponding apparent KM values of the empty ribosome for either elongation factor: from more than 10 microM to 0.5 microM for EF-Tu.GTP by the addition of 0.25 microM EF-G and from 0.7 microM to 0.5 microM for EF-G.GTP by the addition of 3 microM EF-Tu. In a further analysis of this phenomenon, the effects of various specific antibiotics were studied: thiostrepton, fusidic acid, tetracycline, pulvomycin and kirromycin appeared to inhibit the synergistic effect, whereas streptomycin was found to stimulate it. Even in the present minimal system the ribosomes respond to the above-mentioned antibiotics in a way surprisingly similar to that in the coupled system with mRNA and tRNAs. The cooperativity seems not to be due to a simultaneous binding of the two elongation factors to the ribosome as revealed by studying the effects of fusidic acid and kirromycin, and by band-shift experiments by means of gel electrophoresis under non-denaturing conditions. Our experimental data and the kinetic analysis of alternative models provide evidence that EF-Tu.GTP and EF-G.GTP interact sequentially with empty ribosomes that oscillate between two different conformations, one for each elongation factor. Apparently, ribosomes have an intrinsic property for oscillation as normally observed during protein synthesis with a frequency paced by the events of tRNA binding and translocation.


Assuntos
Fatores de Elongação Ligados a GTP Fosfo-Hidrolases/metabolismo , Guanosina Trifosfato/metabolismo , Fator Tu de Elongação de Peptídeos/metabolismo , Fatores de Alongamento de Peptídeos/metabolismo , Ribossomos/metabolismo , Regulação Alostérica/fisiologia , Antibacterianos/farmacologia , Eletroforese , Escherichia coli/metabolismo , Fatores de Elongação Ligados a GTP Fosfo-Hidrolases/efeitos dos fármacos , Cinética , Modelos Biológicos , Fator G para Elongação de Peptídeos , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Fatores de Alongamento de Peptídeos/efeitos dos fármacos , Ligação Proteica , Piridonas/farmacologia , Estreptomicina/farmacologia
9.
J Bacteriol ; 175(1): 240-50, 1993 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8416899

RESUMO

Elongation factor Tu (EF-Tu).GTP has the primary function of promoting the efficient and correct interaction of aminoacyl-tRNA with the ribosome. Very little is known about the elements in EF-Tu involved in this interaction. We describe a mutant form of EF-Tu, isolated in Salmonella typhimurium, that causes a severe defect in the interaction of the ternary complex with the ribosome. The mutation causes the substitution of Val for Gly-280 in domain II of EF-Tu. The in vivo growth and translation phenotypes of strains harboring this mutation are indistinguishable from those of strains in which the same tuf gene is insertionally inactivated. Viable cells are not obtained when the other tuf gene is inactivated, showing that the mutant EF-Tu alone cannot support cell growth. We have confirmed, by partial protein sequencing, that the mutant EF-Tu is present in the cells. In vitro analysis of the natural mixture of wild-type and mutant EF-Tu allows us to identify the major defect of this mutant. Our data shows that the EF-Tu is homogeneous and competent with respect to guanine nucleotide binding and exchange, stimulation of nucleotide exchange by EF-Ts, and ternary complex formation with aminoacyl-tRNA. However various measures of translational efficiency show a significant reduction, which is associated with a defective interaction between the ribosome and the mutant EF-Tu.GTP.aminoacyl-tRNA complex. In addition, the antibiotic kirromycin, which blocks translation by binding EF-Tu on the ribosome, fails to do so with this mutant EF-Tu, although it does form a complex with EF-Tu. Our results suggest that this region of domain II in EF-Tu has an important function and influences the binding of the ternary complex to the codon-programmed ribosome during protein synthesis. Models involving either a direct or an indirect effect of the mutation are discussed.


Assuntos
Fator Tu de Elongação de Peptídeos/genética , Biossíntese de Proteínas , Aminoacil-RNA de Transferência/metabolismo , Ribossomos/metabolismo , Salmonella typhimurium/genética , Antibacterianos/farmacologia , Glicina/metabolismo , Guanosina Trifosfato/metabolismo , Hidrólise , Cinética , Substâncias Macromoleculares , Modelos Moleculares , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/metabolismo , Fenótipo , Conformação Proteica , Piridonas/farmacologia , RNA de Transferência de Fenilalanina/metabolismo , Salmonella typhimurium/metabolismo , Valina/metabolismo
10.
Antimicrob Agents Chemother ; 35(11): 2366-70, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1839491

RESUMO

In a previous study (C. C. Hall, J. D. Watkins, and N. H. Georgopapadakou, Antimicrob. Agents Chemother. 33:322-325, 1989), the elongation factor Tu (EF-Tu) from Staphylococcus aureus was found to be insensitive to a series of kirromycin analogs which were inhibitory to the EF-Tu from Escherichia coli. In the present study, the EF-Tu from S. aureus was partially purified and characterized. Its apparent molecular mass was approximately 41,000 Da, and the enzyme copurified with EF-Ts (molecular mass, 34,000 Da). S. aureus EF-Tu differed from its E. coli counterpart in that it bound negligible amounts of [3H]GDP, in addition to being insensitive to pulvomycin and aurodox (50% inhibitory concentrations, approximately 100 and 1,000 microM, respectively, versus 2 and 0.2 microM, respectively, for E. coli). The results are consistent with the formation of a stable EF-Tu.EF-Ts complex that affects the interaction of EF-Tu with guanine nucleotides and inhibitors.


Assuntos
Aminoglicosídeos , Antibacterianos/farmacologia , Aurodox/análogos & derivados , Escherichia coli/metabolismo , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Peptídeos , Staphylococcus aureus/metabolismo , Adenosina Trifosfatases/metabolismo , Aurodox/farmacologia , Cromatografia DEAE-Celulose , Resistência Microbiana a Medicamentos , Escherichia coli/efeitos dos fármacos , Guanosina Difosfato/metabolismo , Guanosina Trifosfato/metabolismo , Peso Molecular , Biossíntese Peptídica , Fator Tu de Elongação de Peptídeos/isolamento & purificação , Piridonas/farmacologia , Staphylococcus aureus/efeitos dos fármacos
11.
Biochemistry ; 30(27): 6705-10, 1991 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-2065055

RESUMO

We have studied the interaction between EF-Tu-GDP or EF-Tu-GTP in complex with kirromycin or aurodox (N1-methylkirromycin) and aminoacyl-tRNA, N-acetylaminoacyl-tRNA, or deacylated tRNA. Three independent methods were used: zone-interference gel electrophoresis, GTPase stimulation, and fluorescence. All three methods revealed that kirromycin induces a severe drop in the stability of the complex of EF-Tu-GTP and aminoacyl-tRNA of about 3 orders of magnitude. The affinities of EF-Tu-kirromycin-GTP and EF-Tu-kirromycin-GDP for aa-tRNA were found to be of about the same order of magnitude. We conclude that kirromycin and related compounds do not induce a so-called GTP-like conformation of EF-Tu with respect to tRNA binding. The findings shed new light on the mechanism of action of the antibiotic during the elongation cycle. In contrast to indirect evidence previously obtained in our laboratory [Van Noort et al. (1982) EMBO J. 1, 1199-1205; Van Noort et al. (1986) Proc. Natl. Acad. Sci. U.S.A. 71, 4910-4914], we were unable to demonstrate complexes of EF-Tu-aurodox-GTP/GDP with N-acetylaminoacyl-tRNA or deacylated tRNA by direct detection using zone-interference gel electrophoresis. Modification with N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) decreases the affinity of EF-Tu-kirromycin-GTP for aminoacyl-tRNA, just like it does in the absence of the antibiotic.


Assuntos
Escherichia coli/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/metabolismo , Aminoacil-RNA de Transferência/metabolismo , Eletroforese em Gel de Ágar , Escherichia coli/metabolismo , Fatores de Elongação Ligados a GTP Fosfo-Hidrolases/metabolismo , Guanosina Difosfato/metabolismo , Guanosina Trifosfato/metabolismo , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Piridonas/farmacologia , Aminoacil-RNA de Transferência/efeitos dos fármacos , Espectrometria de Fluorescência , Especificidade por Substrato
12.
Biochim Biophys Acta ; 1078(2): 133-8, 1991 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-1648403

RESUMO

The binding of the antibiotic kirromycin to elongation factor Tu (EF-Tu) leads to a severe line broadening of the Q-band manganese EPR lines of EF-Tu.Mn, EF-Tu.Mn.GDP, as well as EF-Tu.Mn.GDP.Pi indicating that the coordination sphere of the metal ion is changed by this interaction. The number of coordinated water molecules was determined from the 17O-55Mn superhyperfine coupling observable in H2(17)O enriched water; it is pH-dependent in the EF-Tu.Mn.GDP complex, at pH 6.8 probably four water molecules are coordinated with the protein bound manganese, at pH 8.4 one of the water molecules is replaced by a functional group from the protein. Independent of the pH, probably four and five water molecules are bound to the metal ion in the EF-Tu.Mn and in the EF-Tu.Mn.GDP.Pi complex, respectively. Kirromycin does not influence the number of water molecules bound to EF-Tu.Mn.GDP and EF-Tu.Mn.GDP.Pi, but leads to an increase of the number of water molecules coordinated to the metal ion in EF-Tu.Mn. The 17O-55Mn superhyperfine coupling constant in Mn(H2O)6 was determined from the EPR-spectra as 0.24 mT.


Assuntos
Antibacterianos/farmacologia , Geobacillus stearothermophilus/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Espectroscopia de Ressonância de Spin Eletrônica , Geobacillus stearothermophilus/metabolismo , Manganês/química , Metais/química , Oxigênio/química , Fator Tu de Elongação de Peptídeos/química , Fator Tu de Elongação de Peptídeos/metabolismo , Piridonas/farmacologia
13.
EMBO J ; 10(4): 779-84, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2009857

RESUMO

The new thiazolyl peptide antibiotic GE2270 A, isolated from Planobispora rosea strain ATCC 53773, is shown to inhibit bacterial protein biosynthesis in vitro by affecting specifically the GTP-bound form of elongation factor Tu (EF-Tu). The 'off' rate of EF-Tu.GTP is slowed down 400-fold, locking GTP on EF-Tu, whereas EF-Tu.GDP is unaffected. Therefore, on the EF-Tu.guanine nucleotide interaction, GE2270 A mimicks the effect of aa-tRNA. In line with this, the binding of aa-tRNA to EF-Tu.GTP is hindered by the antibiotic, as shown by the absence of a stable ternary complex and the inhibition of the enzymatic binding of aa-tRNA to the ribosome. This blocks the elongation cycle. GE2270 A does not essentially modify the intrinsic GTPase activity of EF-Tu, but impairs the stimulation by ribosomes of this reaction. The negative effect of GE2270 A on the EF-Tu.GTP interaction with aa-tRNA bears similarities with that of the structurally unrelated pulvomycin, whereas marked differences were found by comparing the effects of these two antibiotics on EF-Tu.GDP. This work emphasizes the varieties of the transitional conformations which tune the EF-Tu interaction with GTP and GDP.


Assuntos
Aminoglicosídeos , Antibacterianos/farmacologia , Guanosina Trifosfato/metabolismo , Fator Tu de Elongação de Peptídeos/metabolismo , Peptídeos Cíclicos/farmacologia , Escherichia coli/genética , Escherichia coli/metabolismo , Guanosina Difosfato/metabolismo , Cinética , Estrutura Molecular , Elongação Traducional da Cadeia Peptídica/efeitos dos fármacos , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Peptídeos/química , Peptídeos/farmacologia , Peptídeos Cíclicos/química , Ligação Proteica , Ribossomos/metabolismo , Tiazóis/química , Tiazóis/farmacologia
14.
Eur J Biochem ; 193(2): 401-7, 1990 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-2226460

RESUMO

Ricin A chain caused inhibition of protein synthesis by reticulocyte lysate with concomitant depurination of 28S rRNA. The partial reaction(s) of protein synthesis inhibited was investigated by following the appearance of [35S]methionine from initiator [35S]Met-tRNA into 40S ribosomal subunits, 80S monosomes and polysomes. Ricin A chain caused an accumulation of [35S]Met in monosomes which did not enter polysomes. In these respects the effects of the ricin A chain resembled those of diphtheria toxin, an inhibitor of elongation-factor-2-catalyzed translocation. This is consistent with the previously proposed site of action of ricin as an inhibitor of elongation. However, the inhibitory effects of the ricin A chain and diphtheria toxin are not equivalent because we observed that the rate of formation of the 80S initiation complex was reduced approximately sixfold with the ricin A chain relative to diphtheria toxin. Analysis of methionine-containing peptides bound to 80S monosomes in ricin-A-chain-inhibited and diphtheria-toxin-inhibited lysates, programmed with globin mRNA, revealed a predominance of Met-Val, suggesting that the elongation cycle is inhibited at the translocation step. Translocation was also implicated as the step blocked in both the ricin-A-chain-inhibited and diphtheria-toxin-inhibited lysates, by the finding that nascent peptide chains were unreactive towards puromycin. It is concluded that ricin-A-chain-modified ribosomes are deficient in two protein synthesis partial reactions: the formation of the 80S initiation complex during initiation and the translocation step of the elongation cycle.


Assuntos
Globinas/biossíntese , Iniciação Traducional da Cadeia Peptídica/efeitos dos fármacos , Reticulócitos/efeitos dos fármacos , Ricina/farmacologia , Translocação Genética/efeitos dos fármacos , Animais , Centrifugação com Gradiente de Concentração , Cromatografia em Camada Fina , Toxina Diftérica/farmacologia , Técnicas In Vitro , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Biossíntese de Proteínas/efeitos dos fármacos , Purinas/metabolismo , RNA Mensageiro/biossíntese , RNA Mensageiro/efeitos dos fármacos , RNA Ribossômico 28S/efeitos dos fármacos , RNA de Transferência de Metionina/efeitos dos fármacos , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...